Reduced Disease-Free Survival Associated with Anaplastic Lymphoma Kinase Translocation (ALK plus ) in Lung Adenocarcinoma Patients with No Cigarette Smoking History

被引：0
|
作者：
Yang, Ping [1 ]
Oliveira, Andre [2 ]
Wampfler, Jason [1 ]
Boland, Jennifer M. [2 ]
Stoddard, Shawn M. [1 ]
Ericison-Johnson, Michele R. [2 ]
Tang, Hui [1 ]
Kulig, Kimary [1 ]
Yi, Eunhee S. [2 ]
机构：
[1] Mayo Clin, Dept Hlth Sci Res, Rochester, MN 55905 USA
[2] Mayo Clin, Dept Lab Med & Pathol, Rochester, MN 55905 USA
来源：
JOURNAL OF THORACIC ONCOLOGY | 2010年 / 5卷 / 12期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S384 / S384
页数：1
相关论文
共 50 条
  • [1] Anaplastic lymphoma kinase (ALK) mutations in patients with adenocarcinoma of the lung
    Mohamad, N.
    Jayalakshmi, P.
    Rhodes, A.
    Liam, C-K
    Tan, J-L
    Yousoof, S.
    Rajadurai, P.
    [J]. BRITISH JOURNAL OF BIOMEDICAL SCIENCE, 2017, 74 (04) : 176 - 180
  • [2] Worse Disease-Free Survival in Never-Smokers with ALK plus Lung Adenocarcinoma
    Yang, Ping
    Kulig, Kimary
    Boland, Jennifer M.
    Erickson-Johnson, Michele R.
    Oliveira, Andre M.
    Wampfler, Jason
    Jatoi, Aminah
    Deschamps, Claude
    Marks, Randolph
    Fortner, Connie
    Stoddard, Shawn
    Nichols, Francis
    Molina, Julian
    Aubry, Marie-Christine
    Tang, Hui
    Yi, Eunhee S.
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2012, 7 (01) : 90 - 97
  • [3] Survival Benefit of Pemetrexed in Lung Adenocarcinoma Patients With Anaplastic Lymphoma Kinase Gene Rearrangements
    Park, Sojung
    Park, Tai Sun
    Choi, Chang-Min
    Lee, Dae Ho
    Kim, Sang-We
    Lee, Jung-Shin
    Kim, Woo Sung
    Song, Joon Seon
    Lee, Jae Cheol
    [J]. CLINICAL LUNG CANCER, 2015, 16 (05) : E83 - E89
  • [4] Real-world progression-free survival of patients on anaplastic lymphoma kinase (ALK) tyrosine kinase inhibitors (TKIs) for ALK plus non-small cell lung cancer (NSCLC)
    Jahanzeb, M.
    Lin, H. M.
    Pan, X.
    Yin, Y.
    Hou, P.
    Nordstrom, B. L.
    Desai, A.
    Socinski, M. A.
    [J]. ANNALS OF ONCOLOGY, 2018, 29 : 504 - 504
  • [5] Low CFB expression is independently associated with poor overall and disease-free survival in patients with lung adenocarcinoma
    He, Chenglu
    Li, Ya
    Zhang, Ruixian
    Chen, Jing
    Feng, Xingxing
    Duan, Yong
    [J]. ONCOLOGY LETTERS, 2021, 21 (06)
  • [6] Worse disease-free, tumor-specific, and overall survival in surgically-resected lung adenocarcinoma patients with ALK rearrangement
    Gao, Qiongqiong
    Li, Pupu
    Jiang, Xiangli
    Zhan, Zhongli
    Yan, Qingna
    Zhang, Bo
    Huang, Chun
    [J]. ONCOTARGET, 2017, 8 (49) : 86066 - 86081
  • [7] Anaplastic Lymphoma Kinase (ALK)-positive Tumors Clinical, Radiographic and Molecular Profiles, and Uncommon Sites of Metastases in Patients With Lung Adenocarcinoma
    Gupta, Rohan
    Amanam, Idoroenyi
    Rahmanuddin, Syed
    Mambetsariev, Isa
    Wang, Yingyu
    Huang, Charity
    Reckamp, Karen
    Vora, Lalit
    Salgia, Ravi
    [J]. AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2019, 42 (04): : 337 - 344
  • [8] Tumor Differentiation and EGFR Mutation Associated with Disease-Free Survival in Stage IA Lung Adenocarcinoma Patients with Curative Surgery
    Yang, Lu
    Pang, Chong
    Xu, Fei
    Yang, Guangian
    Xu, Haiyan
    Wang, Changli
    Wang, Yan
    [J]. CANCER MANAGEMENT AND RESEARCH, 2020, 12 : 12549 - 12556
  • [9] Economic burden of brain metastases in patients with anaplastic lymphoma kinase positive (ALK plus ) non-small cell lung
    Lin, Huamao Mark
    Pan, Lucy
    Hou, Peijie
    Huang, Hui
    Desai, Avinash
    Jahanzeb, Mohammad
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (30)
  • [10] Rash and Efficacy in Anaplastic Lymphoma Kinase Positive (ALK plus ) Non-Small Cell Lung Cancer Patients Treated with Ensartinib
    Wakelee, H.
    Reckamp, K.
    Leal, T.
    Chiappori, A.
    Waqar, S.
    Zeman, K.
    Neal, J.
    Liang, C.
    Harrow, K.
    Holzhausen, A.
    Zhou, J.
    Selvaggi, G.
    Horn, L.
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (10) : S566 - S566
12345